Overview

Lidocaine Infusions for Chronic Pain in Children

Status:
Recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This is a study to evaluate the efficacy and safety of lidocaine in the management of chronic pain in children. All participants will receive lidocaine infusion and severity of pain and degree of chronic-pain related disability will be assessed before and up to 4 weeks after infusion. Adverse events will be recorded.

Phase:

Phase 3

Details

Lead Sponsor:

The Hospital for Sick Children

Treatments:

Lidocaine